skip to main content

S. 629: Preventing Antibiotic Resistance Act of 2017

A bill to amend the Federal Food, Drugs, and Cosmetic Act to ensure the safety and effectiveness of medically important antimicrobials approved for use in the prevention, control, and treatment of animal diseases, in order to minimize the development of antibiotic-resistant bacteria.

The bill’s titles are written by its sponsor.

Sponsor and status

Dianne Feinstein

Sponsor. Senior Senator for California. Democrat.

Read Text »
Last Updated: Mar 14, 2017
Length: 9 pages

Mar 14, 2017


Introduced on Mar 14, 2017

This bill is in the first stage of the legislative process. It was introduced into Congress on March 14, 2017. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.


2% chance of being enacted according to Skopos Labs (details)


Mar 14, 2017

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Ordered Reported

Passed Senate (House next)

Passed House

Signed by the President

S. 629 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 629 — 115th Congress: Preventing Antibiotic Resistance Act of 2017.” 2017. March 20, 2018 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.